The correct name for Tenofovir is Tenofovir Dipivoxil Fumarate Tablets. Its indications are HIV-1 infection in adults, chronic hepatitis B in adults and pediatric patients 12 years of age and older. Adverse reactions such as renal failure, proximal tubular lesions, dyspepsia, lactic acidosis, steatohepatoma, dyspnea, abdominal pain, rash, myopathy, proteinuria, and debilitation may occur with tenofovir disoproxil fumarate tablets. Tenofovir disoproxil fumarate is contraindicated in patients with prior hypersensitivity to any of the components of this drug, is contraindicated in lactating women, and is used with caution in the elderly. Tenofovir disoproxil fumarate should not be used in combination with fixed-dose combination preparations containing tenofovir. If you need to use Tenofovir Disoproxil Fumarate, please consult a professional doctor, follow the doctor’s instructions, and use medication wisely.